Elevated white blood cell count in subjects with impaired glucose tolerance

Kayo Ohshita1, Kiminori Yamane, Miki Hanafusa

  • 1Department of Molecular and Internal Medicine, Division of Clinical Medical Science, Programs for Applied Biomedicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan. kayoo@hiroshima-u.ac.jp

Diabetes Care
|January 30, 2004
PubMed

Insights

Individuals with isolated impaired glucose tolerance (IGT) had higher white blood cell (WBC) counts than those with isolated impaired fasting glucose (IFG). WBC count is linked to 2-hour plasma glucose and metabolic syndrome components.

Area of Science:

  • Endocrinology
  • Metabolic Syndrome Research
  • Clinical Biochemistry

Background:

  • Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) are distinct prediabetic states with varying mortality risks.
  • Previous studies indicated minimal differences in lipids or blood pressure between IFG and IGT.
  • White blood cell (WBC) count as a potential differentiator between IFG and IGT warrants investigation.

Purpose of the Study:

  • To compare white blood cell (WBC) counts between individuals with isolated impaired fasting glucose (IFG) and isolated impaired glucose tolerance (IGT).
  • To identify factors associated with WBC count in nondiabetic Japanese men.

Main Methods:

  • A cross-sectional study involving 4,720 nondiabetic Japanese men aged 24-84 years.
  • Classification into four groups based on a 75-g oral glucose tolerance test: normal glucose tolerance/normal fasting glucose, isolated IFG, isolated IGT, and IFG/IGT.
  • Comparison of WBC counts among groups and stepwise analysis to identify associated variables.

Main Results:

  • The isolated IGT group exhibited a significantly higher WBC count compared to the isolated IFG group (6,530 vs. 6,210/mm(3), P < 0.05).
  • Age, triglycerides, HDL cholesterol, fasting insulin, and 2-hour postchallenge plasma glucose (PG) were independently associated with WBC count (adjusted R(2) = 0.057).
  • WBC count was independently associated with 2-hour PG and triglycerides, regardless of smoking status.

Conclusions:

  • Isolated impaired glucose tolerance is associated with a higher white blood cell count than isolated impaired fasting glucose.
  • White blood cell count demonstrates an association with 2-hour plasma glucose and key metabolic syndrome components.
  • These findings suggest WBC count may serve as a biomarker differentiating prediabetic states.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.